Startup profile · funding coverage
Garner Health funding, valuation and investors
Employer benefit that ranks in-network doctors on outcomes and reimburses members who see top performers.
Keep track of Garner Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series E
$100M · May 2026
Latest known valuation
$2.74B
Series E · May 2026
Total disclosed equity funding
$218M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York
Investors in latest funding
Lead: Index Ventures
Other: Kleiner Perkins , Redpoint Ventures , Thrive Capital , Sequoia , Founders Fund
Overview
Garner Health is a New York–based employer health benefit that helps members find high-performing in-network doctors and reduces out-of-pocket costs when they use them. Founded in 2019 by CEO Nick Reber, the company analyzes one of the largest U.S. medical claims datasets — over 60 billion records covering 320 million patients — using 550+ specialty-specific quality metrics to identify top providers. Garner operates as a supplemental Health Reimbursement Arrangement layered on existing plans: employees use the Garner app or concierge to book Top Providers, then qualify for reimbursement on qualifying medical bills. The company reports serving nearly 800 employer clients, ~$200M gross ARR doubling YoY for five periods, and average employer healthcare spend reductions of 10%+ in year one.
Why Garner Health is interesting
Garner pairs 60B+ claims records with HRA-style reimbursements so employers can steer members to high-outcome doctors without changing networks — a rare healthtech model with ~800 clients and $2.74B valuation at Series E.
Product & use cases
Garner ranks individual physicians on outcomes and efficiency using merged commercial, Medicare, Medicaid, and price-transparency data, then surfaces Top Providers via app, API, or coordinator UI. Financial incentives — employer-funded HRAs — reward members who choose higher-quality care.
- Employers reducing healthcare spend without changing insurance networks
- Members finding in-network Top Providers by symptom, specialty, or ZIP
- Benefits advisors offering nondisruptive care-navigation add-ons
- Health plans and providers embedding Garner quality scores in referral workflows
Key facts
- Series E (May 2026): $100M led by Index Ventures at $2.74B valuation — PR Newswire
- Series D (Feb 2026): $118M led by Kleiner Perkins at $1.35B valuation
- ~800 employer clients; claims dataset spans 60B+ records and 320M patients
- Reports ~$200M gross ARR doubling YoY for five consecutive periods (HIT Consultant, May 2026)
- CEO Nick Reber founded Garner after personal experience with misdiagnosed back pain and four surgeries
Funding history (newest first)
Series E
2026-05 $100M Valuation: $2.74BInvestors in our directory
Funds linked from Garner Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Bottom-up physician scoring from 60B+ claims — not reviews or directory data — combined with reimbursement mechanics that actually shift member behavior.
Employer care navigation is crowded, but most vendors steer to networks or centers of excellence rather than individual physician quality at scale. Garner's moat is proprietary claims analytics plus HRA mechanics that tie savings to measurable outcomes — Index Ventures cited it as a leading applied-AI use case in healthcare.
-
Accolade direct
Employer health navigation and advocacy; less emphasis on claims-based physician ranking at individual-doctor granularity.
-
Transcarent direct
Employer care navigation and surgery steerage; broader navigation vs. Garner's data-driven provider scoring.
-
Healthgrades adjacent
Consumer physician ratings; lacks Garner's claims depth and employer-funded incentive layer.
-
Castlight Health (Virta Health) incumbent
Legacy employer transparency tools; Garner argues traditional directories miss outcome-based ranking.
Notable stories
- Nick Reber started Garner after four back surgeries traced to misdiagnosis — he concluded healthcare fails because patients lack quality data and financial incentives, not because doctors don't care (MedCity News, May 2026).
- Garner closed $118M Series D in February 2026 and $100M Series E just three months later — an unusually fast double-up reflecting employer demand for measurable cost outcomes.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Garner Health's financing or category context.
FAQs about Garner Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.